Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Offspring Biosciences is a specialized contract research organization (CRO) that provides advanced molecular pathology services to support drug discovery and development. Based in Södertälje, Sweden, the company was founded in 2012 by a team of former AstraZeneca scientists. They offer a comprehensive suite of services, including histopathology, immunohistochemistry, in situ hybridization, and spatial transcriptomics. Offspring Biosciences specializes in target validation, biomarker discovery, and lead optimization, providing high-quality, data-driven insights to global pharmaceutical and biotech clients. In 2021, the company was acquired by Inotiv, enhancing its capabilities and international presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Offspring Biosciences.